COVID-19
Your central place to rapidly access latest news, translated guidance information, and expert interpretations from our former regulators related to COVID-19. Parexel’s 1000+ consulting experts are closely following agency announcements and new guidances and can help provide deep expertise and experience in the race to bring this outbreak to a close. We’re here to fight this with you.
-
View NowCOVID-19 daily Health Authority updates
Updated every day, in a single source
-
Learn MoreBiosimilars in the time of COVID-19 and beyond
Introduction The recent COVID-19 pandemic has triggered a race for pharmaceutical companies to repurpose their commercialized drugs approved for other clinical indications to treat patients...
-
See Parexel's latest COVID-19 expert content
View all -
Learn MoreProtective Antibody Therapy: Preventing Future COVID-19 Outbreaks
About the Authors Dean Giovanniello, RPh., Vice President, co-leads the Health Advances Biopharma...
-
View Now
COVID-19: Gastrointestinal and hepatic manifestations and implications for clinical trials
Parexel expert Michelle Pietzak, MD reviews current findings and offers practical recommendations for gastrointestinal symptoms of COVID-19 and considerations for clinical trials.
-
Learn MoreCoronavirus (COVID-19) Update: Daily Roundup May 29, 2020
Coronavirus (COVID-19) Update: Daily Roundup
-
Learn MoreCoronavirus (COVID-19) Update: Daily Roundup May 29, 2020
Coronavirus (COVID-19) Update: Daily Roundup
-
Learn MoreBringing a Cancer Doctor’s Perspective to FDA’s Response to the COVID-19 Pandemic
During the unprecedented COVID-19 pandemic, the FDA recognizes that there has been public interest around expediting the development and availability of a number of potential treatment options.
-
Learn MoreUnderstanding the Regulatory Terminology of Potential Preventions and Treatments for COVID-19
There are no FDA-approved coronavirus preventions or treatments. Researchers are studying new drugs, and drugs approved for other conditions, as possible preventions or treatments for COVID-19....
-
Learn MoreInternational community rallies to support open research and science to fight COVID-19
WHO and Costa Rica launch landmark COVID-19 Technology Access PoolThirty countries and multiple international partners and institutions have signed up to support the COVID-19 Technology Access...
-
Learn MoreCoronavirus (COVID-19) Update: FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection
FDA taking steps to further support the development of COVID-19 tests for at-home self-collection by including a voluntary EUA template for at-home sample collection kits to its website.
-
Learn MoreStayWell Copper Products - 607773 - 05/28/2020
Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)
-
Learn MoreQuadrant Sales & Marketing, Inc. - 607625 - 05/28/2020
Unapproved New Drug Products Related to Coronavirus Disease 2019 (COVID-19)
-
Learn More
COVID-19: reminder of the risks of chloroquine and hydroxychloroquine , , 29/05/2020
EMA is reminding healthcare professionals to closely monitor patients with COVID-19 who are receiving chloroquine or hydroxychloroquine, given the...
-
Learn More
Screening for Covid-19 in Skilled Nursing Facilities
New England Journal of Medicine, Ahead of Print.
-
Learn MoreCoronavirus (COVID-19) Update: Daily Roundup May 28, 2020
Coronavirus (COVID-19) Update: Daily Roundup
-
Learn More
Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #3, , 28/05/2020
As part of its coordinated response to the pandemic, the International Coalition of Medicines Regulatory Authorities (ICMRA) convened its regular high-...
-
Learn MoreAlternavita - 607147 - 05/26/2020
Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)
-
Learn More
Essential work to combat the COVID-19 pandemic to continue during EMA's closure on 1 June 2020, , 28/05/2020
EMA has put measures in place to ensure that its activities related to the COVID-19 pandemic can continue during the Agency's closure on 1 June 2020....
-
Learn More
European medicines regulatory network fully mobilised in fight against COVID-19, , 28/05/2020
The development and availability of medicines and vaccines for all patients in the European Union, including those with COVID-19, is the number one...
-
Learn MoreCOVID-19 intensifies the urgency to expand sustainable energy solutions worldwide
Despite accelerated progress over the past decade, the world will fall short of ensuring universal access to affordable, reliable, sustainable, and modern energy by 2030 unless efforts are scaled...
-
Loading More...
